Drug intelligence / Profile preview

coca leaf

Development stage
Unknown
Lead developer
Magdalena Biosciences
Modality
Small Molecules
Administration
Oral, Buccal
01

Overview

Coca leaf refers to the foliage of the *Erythroxylum coca* and *Erythroxylum novogranatense* plants, native to western South America. It contains a complex profile of alkaloids, the most pharmacologically significant being cocaine (benzoylmethylecgonine), which constitutes approximately 0.25% to 0.77% of the leaf's mass. The primary mechanism of action involves the inhibition of the reuptake of monoamine neurotransmitters—dopamine, norepinephrine, and serotonin—by binding to their respective transporters. This results in increased synaptic concentrations of these neurotransmitters, leading to stimulant, anorectic, and euphoric effects. Additionally, the alkaloids act as local anesthetics by blocking voltage-gated sodium channels. Traditionally, the leaves are chewed or consumed as a tea (mate de coca) to alleviate symptoms of altitude sickness (soroche), fatigue, and hunger. While the whole leaf is a controlled substance under international law, it remains a significant cultural and medicinal staple in Andean nations and serves as the raw material for the pharmaceutical production of cocaine hydrochloride and decocainized flavoring agents.

Other names
Erythroxylum cocaErythroxylum novogranatensekukamate de coca
02

Targets

DAT (Dopamine plasma membrane transport protein)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on coca leaf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on coca leaf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call